Cell Specificity in DNA Damage and Repair

  • James A. Swenberg
  • Mary A. Bedell
  • Kathryn C. Billings
  • James G. Lewis
Part of the Basic Life Sciences book series


Many animal models for organ-specific neoplasia have been developed and used to investigate the pathogenesis of cancer. Studies dealing with morphologic aspects of this disease process have frequently concentrated on target cells. In contrast, most biochemical studies have employed whole organ homogenates even though tumors only develop from specific subpopulations of the target organ. For example, hepatocytes are the target cell for nitrosodiethylamine (DEN), 2-acetylaminofluorene, and dinitrotoluene, while sinusoidal lining cells represent the primary targets for vinyl chloride and 1,2-dimethylhydrazine (SDMH). Although hepatocytes comprise more than 90% of the liver’s mass, they account for only 60 to 70% of its cells. The nonparenchymal cells (NPC) account for the remaining 30 to 40% of the cells and 10 to 20% of the DNA. Thus, localization of carcinogen metabolism or DNA damage and repair within susceptible and nonsusceptible cell populations requires separation of cell types.


Vinyl Chloride Cell Replication Micrococcus Luteus Nonparenchymal Cell Nontarget Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lewis, J.G., and J.A. Swenberg. 1980. Differential repair of O6-methylguanine in DNA of rat hepatocytes and nonparenchymal cells. Nature 288: 185–187.PubMedCrossRefGoogle Scholar
  2. 2.
    Sanderson, R.J., and K.E. Bird. 1977. Cell separations by counterflow centrifugation. In: Methods in Cell Biology, Volume 15. D.M. Prescott, ed. Academic Press: New York. pp. 1–14.CrossRefGoogle Scholar
  3. 3.
    Wisse, E., and D.L. Knook. 1979. The investigation of sinusoidal cells: A new approach to the study of liver function. In: Progress in Liver Disease, Volume VI. H. Popper and F. Schaffner, eds. Grune and Stratton: New York. pp. 153–171.Google Scholar
  4. 4.
    Druckrey, H. 1972. Organospecific carcinogenesis in the digestive tract. In: Topics in Chemical Carcinogenesis. W. Nakahara, S. Takayama, T. Sugimura, and S. Odashima, eds. University Park Press: Tokyo. pp. 73–101.Google Scholar
  5. 5.
    Druckrey, H. 1970. Production of colon carcinomas by 1,2-dialkylhydrazines and azoalkanes. In: Carcinoma of the Colon and Antecedent Epithelium. W.J. Burdette, ed. Charles C. Thomas: Springfield. pp. 267–279.Google Scholar
  6. 6.
    Weisburger, J.H., R.M. Madison, J.M. Ward, C. Viguera, and E.K. Weisburger. 1975. Modification of diethylnitrosamine liver carcinogenesis with phenobarbital but not with immunosuppression. J. Natl. Cancer Inst. 54: 1185–1188.Google Scholar
  7. 7.
    Herron, D.C., and R.C. Shank. 1979. Quantitative high pressure liquid chromatographic analysis of methylated purines in DNA of rats treated with chemical carcinogens. Anal. Biochem. 100: 58–63.Google Scholar
  8. 8.
    Lewis, J.G., M.A. Bedell, K.C. Billings, and J.A. Swenberg. 1981. Differences in DNA alkylation, repair and replication in hepatocytes and nonparenchymal cells (NPC) following chronic administration of 1,2-dimethylhydrazine (SDMH). Proc. Am. Assoc. for Cancer Res. 22: 75.Google Scholar
  9. 9.
    Laval, J., J. Pierre, and F. Laval. 1981. Release of 7-methylguanine residues from alkylated DNA by extracts of Micrococcus luteus and Escherichia cola. Proc. Natl. Acad. Sci. 58: 852–855.Google Scholar
  10. 10.
    Singer, B., and T.P. Brent. 1981. Human lymphoblasts contain DNA glycosylase activity excising N-3 and N-7 methyl and ethyl purines but not 0 6-alkylguanines or 1-alkyladenines. Proc. Natl. Acad. Sci. 78: 856–860.Google Scholar
  11. 11.
    Margison, G.P., and A.E. Pegg. 1981. Enzymatic release of 7-methylguanine from methylated DNA by rodent liver extracts. Proc. Natl. Acad. Sci. 78: 861–865.Google Scholar
  12. 12.
    Pegg, A.E. 1978. Enzymatic removal of O6-methylguanine from DNA by mammalian cell extracts. Biochem. Biophys. Res. Comm. 84: 166–173.Google Scholar
  13. 13.
    Pegg, A.E., and G. Hui. 1978. Formation and subsequent removal of O6-methylguanine from deoxyribonucleic acid in rat liver and kidney after small doses of dimethylnitrosamine. Biochem. J. 173: 739–748.Google Scholar
  14. 14.
    Pegg, A.E. 1980. Formation and subsequent repair of alkylation lesions in tissues of rodents treated with nitrosamines. Arch. Toxicol. Suppl. 3: 55–68.Google Scholar
  15. 15.
    Montesano, R., H. Brisel, G. Planche-Martel, G.P. Margison, and A.E. Pegg. 1980. The effect of chronic treatment of rats with dimethylnitrosamine on the removal of 06-methylguanine from DNA. Cancer Res. 40: 452–458.PubMedGoogle Scholar
  16. 16.
    Medcalf, A.S.C., and P.D. Lawley. 1981. Time course of 0 6-methylguanine removal from DNA of N-methyl-N-nitrosoureatreated human fibroblasts. Nature 289: 796–798.PubMedCrossRefGoogle Scholar
  17. 17.
    Farber, E. 1980. The sequential analysis of liver cancer induction. Biochim. Biophys. Acta 605: 149–166.PubMedGoogle Scholar
  18. 18.
    Pitot, H.C., and A.E. Sirica. 1980. The stages of initiation and promotion in hepatocarcinogenesis. Biochim. Biophys. Acta 605: 191–215.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • James A. Swenberg
    • 1
  • Mary A. Bedell
    • 1
  • Kathryn C. Billings
    • 1
  • James G. Lewis
    • 2
  1. 1.Department of PathologyChemical Industry Institute of ToxicologyResearch Triangle ParkUSA
  2. 2.Department of PathologyDuke University Medical CenterDurhamUSA

Personalised recommendations